WHO Guidelines for the production and quality control of monoclonal antibodies and related products intended for medicinal use, TRS 1043, Annex 4

Overview

Although these Guidelines are primarily intended to provide guidance on regulatory considerations and requirements for marketing authorization purposes, reference is also made throughout the document to products within their clinical development programmes. Such guidance is provided to highlight issues which may be important to consider during the product development process.